Tuesday, March 03, 2026 8:08:36 PM
With INBS saying data analysis by the end of the month?
The heavy sell off from $21 (post the r/split)...
I was thinking the same thing when it dipped below $4.
There was a heck of a VOLUME day on the 26th of Feb. That is 'oft'
seen as a 'signal' that the downtrend may have run its course. Not saying
it can't go lower if no buyers show up. But you get that much churn in one day
and it tends to signal those 'shorting/selling' may have at least covered.
So will see, but at this price level, the low share count, low market cap?
Decided I SHOULD end up being happy with the prices I just paid.
That is IF they get approved and don't have to dilute much more. (smile)
The heavy sell off from $21 (post the r/split)...
I was thinking the same thing when it dipped below $4.
There was a heck of a VOLUME day on the 26th of Feb. That is 'oft'
seen as a 'signal' that the downtrend may have run its course. Not saying
it can't go lower if no buyers show up. But you get that much churn in one day
and it tends to signal those 'shorting/selling' may have at least covered.
So will see, but at this price level, the low share count, low market cap?
Decided I SHOULD end up being happy with the prices I just paid.
That is IF they get approved and don't have to dilute much more. (smile)
Recent INBS News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 03:24:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 12:30:46 PM
- Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:00:55 PM
- Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified • GlobeNewswire Inc. • 04/17/2026 12:30:00 PM
- Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:30:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/23/2026 08:10:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:26 PM
- Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry • GlobeNewswire Inc. • 02/25/2026 01:45:00 PM
- Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout • GlobeNewswire Inc. • 02/24/2026 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:55:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 01:31:15 PM
- Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year • GlobeNewswire Inc. • 02/12/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:53:26 PM
- Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year • GlobeNewswire Inc. • 02/05/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 10:15:25 PM
- Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
